Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
371
TEVA
Teva Pharmaceutical Industries Limited American Depositary Shar
36.44 USD-3.09%-2.07%+6.08%+90.74%42.46 B USD
442
ZTS
Zoetis Inc. Class A Common Stock
77.35 USD+3.12%-0.19%+0.45%-47.14%31.96 B USD
618
VTRS
Viatris Inc. - Common Stock
16.34 USD-3.26%+0.49%-7.32%+57.87%18.77 B USD
688
NBIX
Neurocrine Biosciences, Inc. - Common Stock
154.06 USD-1.19%+0.98%-13.93%+6.25%15.66 B USD

Frequently asked questions about Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

What is the Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) stock price today?

The current price of Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) is 18.04. Over the past 24 hours, the stock has changed by 0.00%. Follow the TAK chart for real-time price dynamics.

What is the stock ticker of Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)?

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades under the ticker TAK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) stock going up?

TAK has changed by -0.93% over the last week, +5.37% over the last month, and +27.18% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)?

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) currently has a market capitalization of 28.1 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) release financial reports?

Yes. You can track Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) have?

As of the latest available data, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) has 47.03 K employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) stock?

You can buy Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) stock?

Investing in Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TAK chart and related analysis on metatrader.com as part of your research.

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect".

News